Abstract 5208
Background
Length time bias is a form of selection bias that lead to the perception that screened patients have better outcome as more indolent tumors are diagnosed during screening. However, tumors diagnosed in the interval between mammographys or detected by symptom onset are likely more aggressive. The aim was to analyze using a genomic platform if unscreened tumors were more agresive than screened ones in a homogeneous cohort not affected by stage or subtype.
Methods
Since 2014 BC pts with T1-T2 N0-N1mic tumors and/or high ki67 are selected for genomic platform-based risk assessment in order to guide adjuvant treatment. We performed an exploratory retrospective cohort study in a single institution between 2014 and 2018 in operated stage I-IIA BC pts with ER and/or PR + who underwent an Oncotype risk assessment before deciding adjuvant therapy. Results of the Recurrence score (RS) were compared according to the type of diagnosis of breast cancer as 1) Screened: Diagnosis during screening (when diagnosed occurred during a foreseen mammography visit) and 2) Unscreened: Diagnosis occurred outside screening (in an interval between mammographys or by symptom onset).
Results
105 pts were included. Median age was 56.4 y (45.2-74.6 y). All patients were ER + (range 50-100%), HER2- and grade was I (12.4%) II (82,9%) or III (4.8%). Median tumor size was 13.7 mm (4-45). 89.5% were N0 and 10.5% N1mic. 68 pts (64.8%) were in the screened and 37 (35.3%) in the unscreened group. Foreseen adjuvant treatment was changed according to Oncotype results in 24.8% patients. Median RS was 18.2 (range 3-46). According to RS risk categories 81% were classified as low , 9.5% as intermediate and 9.5% as high risk. Median RS was 17.6 in the screened vs 19.2 in the unscreened group, these differences were not significant (p = 0.34). Differences by RS categories were also not significant (Chi square p = 0.67 for two categories low vs intermediate/high risk with a RR 0.92 (0.62-1.38) and p = 0.2 for three categories).
Conclusions
No risk differences according to RS was seen between screened vs unscreened patients. These suggest that length time bias in a cohort not affected by stage or subtype might have mínimum impact on screening outcomes.
Clinical trial identification
Legal entity responsible for the study
Hospital Clinico Universitario de Valencia. INCLIVA.
Funding
Has not received any funding.
Editorial Acknowledgement
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
2069 - The concordance with antiemetic guideline for pediatric, adolescent and young adult patients with cancer using a large-scale administrative database.
Presenter: Seiko Bun
Session: Poster display session: Breast cancer - early stage, locally advanced & metastatic, CNS tumours, Developmental therapeutics, Genitourinary tumours - prostate & non-prostate, Palliative care, Psycho-oncology, Public health policy, Sarcoma, Supportive care
Resources:
Abstract
2740 - Effectiveness of surgical glove compression therapy as a prophylactic method against nab-Paclitaxel induced peripheral neuropathy
Presenter: Shigeru Tsuyuki
Session: Poster display session: Breast cancer - early stage, locally advanced & metastatic, CNS tumours, Developmental therapeutics, Genitourinary tumours - prostate & non-prostate, Palliative care, Psycho-oncology, Public health policy, Sarcoma, Supportive care
Resources:
Abstract
2229 - Effect of oral magnesium supplementation on the kinetics of magnesium wasting induced by EGFR targeted antibody therapy for colorectal carcinoma (MAGNET trial)
Presenter: Hubert Piessevaux
Session: Poster display session: Breast cancer - early stage, locally advanced & metastatic, CNS tumours, Developmental therapeutics, Genitourinary tumours - prostate & non-prostate, Palliative care, Psycho-oncology, Public health policy, Sarcoma, Supportive care
Resources:
Abstract
4155 - Pilot and definitive randomised double-blind placebo-controlled trials evaluating an oral cannabinoid-rich THC/CBD cannabis extract for secondary prevention of chemotherapy-induced nausea and vomiting (CINV)
Presenter: Antony Mersiades
Session: Poster display session: Breast cancer - early stage, locally advanced & metastatic, CNS tumours, Developmental therapeutics, Genitourinary tumours - prostate & non-prostate, Palliative care, Psycho-oncology, Public health policy, Sarcoma, Supportive care
Resources:
Abstract
2473 - Pregnancies after breast cancer, is there a real need for fertility preservation ? Results from the ARTEMIS cohort of 60 young patients
Presenter: Jerome Martin-Babau
Session: Poster display session: Breast cancer - early stage, locally advanced & metastatic, CNS tumours, Developmental therapeutics, Genitourinary tumours - prostate & non-prostate, Palliative care, Psycho-oncology, Public health policy, Sarcoma, Supportive care
Resources:
Abstract
3450 - Inclusion of adolescents in adult early phase trials and young adults in paediatric early phase trials: a reality or a myth?
Presenter: Aurore Vozy
Session: Poster display session: Breast cancer - early stage, locally advanced & metastatic, CNS tumours, Developmental therapeutics, Genitourinary tumours - prostate & non-prostate, Palliative care, Psycho-oncology, Public health policy, Sarcoma, Supportive care
Resources:
Abstract
2917 - Indicators of non-uptake of breast cancer screening: results from the EDIFICE 6 survey
Presenter: Jean-Francois Morere
Session: Poster display session: Breast cancer - early stage, locally advanced & metastatic, CNS tumours, Developmental therapeutics, Genitourinary tumours - prostate & non-prostate, Palliative care, Psycho-oncology, Public health policy, Sarcoma, Supportive care
Resources:
Abstract
2920 - Benefits of physical activity and sport integrated into the care pathway of oncology patient
Presenter: Laurence Vanlemmens
Session: Poster display session: Breast cancer - early stage, locally advanced & metastatic, CNS tumours, Developmental therapeutics, Genitourinary tumours - prostate & non-prostate, Palliative care, Psycho-oncology, Public health policy, Sarcoma, Supportive care
Resources:
Abstract
5334 - Identifying barriers to physical activity in patients with lung cancer: an Australian pilot study
Presenter: Quan Tran
Session: Poster display session: Breast cancer - early stage, locally advanced & metastatic, CNS tumours, Developmental therapeutics, Genitourinary tumours - prostate & non-prostate, Palliative care, Psycho-oncology, Public health policy, Sarcoma, Supportive care
Resources:
Abstract
6108 - Quality of life, late effects, and related clinical factors among Korean colorectal cancer survivors
Presenter: Ji Soo Park
Session: Poster display session: Breast cancer - early stage, locally advanced & metastatic, CNS tumours, Developmental therapeutics, Genitourinary tumours - prostate & non-prostate, Palliative care, Psycho-oncology, Public health policy, Sarcoma, Supportive care
Resources:
Abstract